BCAL Diagnostics Launches BREASTEST plus, Achieving First Revenues.

BCAL Diagnostics Limited (ASX: BDX) has officially launched BREASTEST plus, a first-in-class blood test for breast cancer screening, generating its first sales revenue. Available from 27 March 2025, this test addresses the challenge of high breast density, which affects 50% of Australian women and often makes traditional mammography less effective. The test will initially be available at Sydney Breast Clinic, with a national rollout planned in partnership with clinical experts. 

In a significant milestone, BCAL has also secured Australian Patent No. 2023258393, ensuring intellectual property protection for its innovative diagnostic methods through 2043. The company holds exclusive global rights for lipidomic-based cancer diagnostics. CEO Shane Ryan emphasized that this groundbreaking test enhances early detection pathways, reinforcing BCAL’s leadership in non-invasive breast cancer diagnostics. With strategic expansion and patent protection, BCAL is poised for long-term success in revolutionizing breast cancer screening.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com